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SAMMANFATTNING 
Syftet med denna uppsats var att göra en litteraturstudie på aortakroppstumörer på hund. 
Tumörernas patofysiologi, diagnostiska metoder, makroskopiskt och mikroskopiskt utseende 
beskrivs. Aortakroppstumörer utgår från kemoreceptorerna belägna vid hjärtbasen och tillhör 
gruppen kemodektom. Kemoreceptorerna är neuroendokrina celler vars uppgift är att bland 
annat övervaka ändringar i pH i blodet. 
Tumörerna utgör endast 7 % av alla hjärttumörer på hund men trots den låga prevalensen är 
dessa tumörer den näst vanligaste typen av primär hjärttumör. Tumörerna är kliniskt viktiga 
då de kan ge upphov till bland annat hjärtsvikt och hjärttamponad. Bland brachycephala raser 
såsom Boxer, Boston bullterrier och Engelsk bulldog är prevalensen högre. Det finns dock 
brachycephala raser t.ex. Mops där prevalensen inte är högre än genomsnittet bland alla raser. 
Etiologin är till stor del okänd, dock finns det teorier om en genetisk och/eller 
raspredisposition. Kronisk hypoxi och ”Brachycephalic airway syndrome” tros vara möjliga 
orsaker till att aortakroppstumörer uppstår. 
Tumörerna mäter 0,5 – 12,5 cm i diameter och komplikationer uppkommer allt eftersom 
tumören ökar i storlek. Aortakroppstumörer kan upptäckas med hjälp av ultraljud eller 
röntgen. Tumörerna är oftast benigna men är expansiva vilket orsakar många av symptomen. 
Symptom kan även orsakas av infiltration av tumören. Diagnosen kan fastställas med 
histologisk färgning, hematoxylin- och eosinfärgning, i kombination med 
immunohistokemiska metoder såsom märkning med antikroppar t.ex. chromogranin A. 
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SUMMARY  
The purpose of this essay was to review the literature and describe the patophysiology, 
diagnosis, microscopic and macroscopic appearance of aortic body tumors in dogs. The 
tumors originate from the chemoreceptor organs situated at the base of the heart. The 
chemoreceptor organs are neuroendocrine cells responsible for surveillance of changes in e.g. 
the blood pH.  
Aortic body tumors are rare and represent 7 % of the total cases of primary cardiac tumors in 
canines. Despite their low prevalence the tumors are the second most common cardiac tumor. 
However, they are of clinical importance because they can cause cardiac failure and cardiac 
tamponade among other symptoms. Brachycephalic breeds such as Boxers, Boston bull 
terriers and English bulldogs have a high prevalence. However, there are other brachycephalic 
breeds e.g. Pugs where the prevalence is not higher than the average among all breeds. The 
etiology is not fully known but reports indicate a genetic and/or breed predisposition. 
Theories suggest that chronic hypoxia and “Brachycephalic airway syndrome” serves as 
contributing factors.  
The tumors measure 0,5 – 12,5 cm in diameter and the size of the tumor determines the 
symptoms including cardiac failure and cardiac tamponade. A benignant behavior is mostly 
seen and the tumors are expansive which causes many of the symptoms. There are also 
infiltrative tumors and they cause symptoms as well though they are less common. Tumors 
can be discovered by ultrasonography or radiography and diagnosis can be confirmed with 
histological stains such as hematoxylin and eosin staining together with 
immunohistochemistry by labeling the tumor with a neuroendocrine marker e.g. 
chromogranin A.  
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INTRODUCTION 
The aortic body tumor is the second most common cardiac tumor after hemangiosarcoma. The 
tumor arises from the chemoreceptor organs in the aorta and is sometimes called 
chemodectoma. Cardiac tumors are not by far as common as mammary tumors and aortic 
body tumors are rare. However, they are of great clinical importance because of the lesions 
they give rise to. As a practicing veterinarian it is important to be aware of their existence and 
the symptoms of an aortic body tumor. Aortic body tumors can cause life threatening 
symptoms such as congestive heart failure, sudden death and pericardial effusion. The 
purpose of this essay is to describe the patophysiology of aortic body tumors in dogs. The 
macroscopic and microscopic appearance will be described together with diagnosis, etiology 
and prognosis. 
 
MATERIALS AND METHODS 
Most of the articles were found in PubMed where following search terms were used for 
searching articles; “Chemodectoma AND dog OR canine”, ““heart base tumor” AND dog OR 
canine” and ““aortic body tumor” AND dog OR canine”. Google scholar and Science direct 
were also used for finding articles and with the same phrases as written above.  
Through the articles found, their sources were traced and used in this essay if relevant. Since 
the subject is not fully explored scientifically further demarcation was not necessary except 
for the one already made through the “search terms”.  
 REVIEW OF THE LITERATURE 
Chemodectoma represents both aortic body tumors and carotid body tumors (Ehrhart et al., 
2002). An aortic body tumor arises from the chemoreceptor organs that are localized in the 
tunica adventitia of the aortic arch. The carotid body tumor arises from the chemoreceptor 
organs in the carotid artery.  The chemoreceptor organs are clusters of neuroendocrine cells 
that detect changes in blood pH, oxygen and carbon dioxide pressure and temperature 
(McGavin & Zachary, 2007). Aortic body tumors are four to five times more common than 
carotid body tumors in dogs (Deim et al., 2007). The tumors are rare in other domestic 
animals but have been reported in cats (Yates et al., 1980). Synonyms include cardiac 
paraganglioma, heart base tumor, APUDoma and glomus body tumor (Ehrhart et al., 2002).  
Aortic body tumors are non-functional but can create lesions when they increase in size and 
exert pressure on surrounding organs i.e. the trachea or cardiac atria (Withrow & Veil, 2007). 
The tumors are of clinical relevance because they can cause hemorrhages and cardiac failure. 
The tumors are mostly benign but 22 % will eventually metastasize (Yates et al., 1980). In 
addition to Yates; Atasever & Çam (2003) states that the aortic body tumors seldom 
metastases; instead they have a tendency of being infiltrative. But when found, the metastases 
are mostly in the lungs and liver but can also be found in the brain, the mediastinum, the 
bones, the kidney, the adrenal cortex, the spleen, mediastinal lymph nodes, the dura mater in 
the cerebellum and in the myocardium (Noszczyk-Nowak et al., 2010; Atasever & Çam, 
2003; Yates et al., 1980).  
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Malignant aortic body tumors are larger and less common than benign forms. The malignant 
tumors are primarily locally invasive and can infiltrate the wall of the pulmonary artery, the 
epicardium, pericardium, lymph nodes, lungs and the wall of the atria (DiFruscia et al., 1989; 
Withrow & Veil, 2007). However, they seldom metastases to the liver or lungs (McGavin & 
Zachary, 2007) 
The aortic body tumor is the second most common cardiac tumor, after hemangiosarcoma, 
and represents 7 % of all primary cardiac tumors in dogs (Ware & Hopper, 1999). But 
primary cardiac tumors are rare (Aupperlea et al., 2007) and aortic body tumors are 
incidentally found at necropsy without having caused clinical symptoms while the dog was 
alive (Atasever & Çam, 2003). According to Yates et al. (1980) the tumors might be more 
prevalent than believed because small tumors might be overlooked during necropsy because 
of their location and size.  
Etiology  
Aortic body tumors are most common in brachycephalic breeds where Boxers, Boston bull 
terriers and English bulldogs are considered predisposed. However, German shepherds, a non-
brachycephalic breed, have a higher incidence of the tumors. One theory suggests that chronic 
hypoxia causes the chemoreceptor cell hyperplasia (Withrow & Veil, 2007) which can result 
in neoplasia of the chemoreceptor cells (Noszczyk-Nowak et al., 2010). The incidence of 
aortic body tumors is higher in dogs aged 6 years or older but the incidence is lower in dogs 
aged 15 or older (Atasever & Çam, 2003; Ware & Hopper, 1999). Yates et al. (1980) reported 
tumors in dogs aged 2-15 years, medium age 10 years and that Boxer and Boston bull terriers 
were predisposed breeds. Ware & Hopper (1999) reported a 3,8 times higher relative risk for 
spayed females than for intact females. But there were no significant difference in incidence 
between castrated and non-castrated males. Neither, there was a significant difference 
between spayed females and castrated males. However, the relative risk of aortic body tumors 
for intact males was 3,52 times higher than for intact females.   
The etiology is not fully known. Noszczyk-Nowak et al. (2010) describe, in their article, a 
theory about why Boxers are predisposed of aortic body tumors. The predisposition may be a 
result of chronic hypoxia due to the fact that they are brachycephalic and thereby suffer from 
“Brachycephalic airway syndrome” (BAS). The characteristics of BAS are elongated soft 
palate, stenotic nostrils, and lesions in the soft tissue of the pharynx due to a rostral shortage 
of the skull. The lesions cause a resistance of the airflow in the upper respiratory tract and 
give a higher negative pressure during inspiration which can result in secondary lesions such 
as collapse of the larynx. The soft tissue lesions result in chronic hypoxia which is suspected 
to cause hyperplasia of the chemoreceptor cells. The hyperplasia can transform into 
chemoreceptor cell neoplasia.  
Hayes (1975) performed an etiological study from which he drew the conclusion that breeds 
from Bulldog ancestry are at risk for aortic body tumors. Bulldog breeds consist of 
individuals distantly related to each other. The genetic predisposition together with 
aggravation by the stimulation of high pCO2 and low pO2 resulted in the high frequency of 
chemodectomas within these breeds. 
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In a study performed by Noszczyk-Nowak et al. (2010) a blood gas measurement was done on 
dogs with aortic body tumors. The dogs showed symptoms of a compensated respiratory 
acidosis with low pO2, high pCO2, normal pH and less base excess. A big aortic body tumor 
can cause respiratory acidosis but in the study even dogs with small tumors suffered from 
respiratory acidosis. But the theory does not include all brachycephalic breed e.g. Pugs does 
not have a higher prevalence than other non-brachycephalic breeds (Noszczyk-Nowak et al., 
2010). 
Macroscopic appearance 
Tumors range in size from 0,5 – 12,5 cm and appear as a grey single mass or multiple nodules 
with a mosaic pattern. The tumors have smooth external surface and have a spongy 
consistency (DiFruscia et al., 1989; Arlington- Headley et al., 2009; Noszczyk-Nowak et al., 
2010). The cross section is white and mottled with areas shifting from brown to red 
(Arlington- Headley et al., 2009). The tumors have a rich blood supply and contain necrotic 
and hemorrhagic areas and areas with severe inflammation (Balaguer et al., 1990).  
Malignant forms have a network of capillaries, muscular arterioles and thin walled veins. 
Focal hemorrhages and a necrotic center can be observed within tumors greater that 8 cm. 
They can infiltrate the walls of the surrounding vessels and atrium (Noszczyk-Nowak et al., 
2010). 
Histological appearance 
The tumor is divided into lobules by a connective tissue stroma and these are further divided 
into smaller lobules by collagen and reticulin (Atasever & Çam, 2003). The cells are 
pleomorphic and surrounded by a fibrous capsule infiltrated with neoplastic cells (Balaguer et 
al., 1990). Two different cell types are most abundant, the neuroendocrine type I cells and the 
sustentacular or supporting type II cells. The type I cells are big, cubical to polyhedral with a 
small amount of lightly eosinophilic, granular cytoplasm containing vacuoles. The nucleus is 
big, round to oval or deranged/ deformed and contains nucleoli. The nucleus lacks chromatin 
and few mitoses are present (Aresu et al. 2006; Yates et al. 1980; Atasever & Çam, 2003; 
Balaguer et al., 1990). The type II cells are spindle-shaped and distributed in the periphery of 
the tumor (Atasever et al., 2006).  
The tumor also contains giant mononuclear cells scattered around with hyperchromatic nuclei 
(Balaguer et al., 1990). Around the border of the tumor a lymphohistiocytic inflammatory 
infiltrate can be observed (Noszczyk-Nowak et. al., 2010). Scattered in the neoplasm; there is 
another cell type that lies in clusters or one by one with indistinct boundaries. They have a 
sparse cytoplasm and are characterized by a tightly packed, small nucleus surrounded by a 
small amount of eosinophil cytoplasm (Balaguer et al., 1990). 
Malignant forms have a rich blood supply and numerous mitoses can be observed locally 
within the tumor (Noszczyk-Nowak et al., 2010).  
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Symptoms 
Clinical signs of an aortic body tumor are often diffuse and the size and localization of the 
tumor determines the symptoms and their severity (Nowakowski, H., DVM, PhD, pers. com., 
2011). 
Hemorrhages from the tumor and congestive heart failure are the most common clinical 
effects of the tumors (Yates et al., 1980). When they increase in size they create functional 
disturbances such as compression of the aorta and vena cava which causes cardiac 
decompensation (McGavin & Zachary, 2007). The tumors cause pericardial effusion, 
dyspnea, hydrothorax, hydropericardium, fatigue, edema, cough, weight loss, vomiting and 
Vena Cava syndrome (Withrow & Veil, 2007; Noszczyk-Nowak et al., 2010). Hydrothorax 
and the pressure the tumor exerts on the main bronchus cause the dyspnea (Noszczyk-Nowak 
et al., 2010). The pressure the tumors exert on the heart might lead to increased diastolic 
pressure which in turn leads to right cardiac atria failure which causes cardiac tamponade 
(Ehrhart et al., 2003). Cardiac tamponade can sometimes be mistaken for an epileptic seizure, 
by the owners, because it causes the animals to faint (Nowakowski, H., DVM, PhD, pers. 
com., 2011).  
The most common symptom associated with aortic body tumor is cardiac failure but Yates et 
al. (1980) found that hemorrhages that caused acute respiratory or cardiac embarrassment 
were of equal importance. The tumors are locally expansive and may compress the 
esophagus, trachea, heart and major vessels. Some tumors are invasive and can invade vessels 
and thereby cause impeded flow of blood and lymph which can result in congestive heart 
failure and hydropericardium (Yates et al., 1980).  
Pericardial effusion is a life threatening condition and dogs with pericardial effusion show 
signs of weakness, dyspnea, exercise intolerance, weight loss, abdominal distention and right 
sided congestive heart failure (Shaw & Rush, 2007). Prognosis is poor for dogs with 
pericardial effusion as a result of an aortic body tumor according to Fine et al., 2003 while 
Owen et al. (1996) states that the prognosis is fair. Because of their location; aortic body 
tumors are difficult to remove surgically (DiFruscia et al., 1989). Therefore DiFruscia 
recommends pericardiocentesis or in certain cases; subtotal pericardectomy as conservative 
therapy to ease the symptoms of pericardial effusion.  Radiation therapy has not been used 
enough therefore it is hard to judge the efficiency of it (Owen et al., 1996). Without treatment 
the dogs will have resistant or progressive pericardial effusion causing cardiac tamponade and 
eventually death (Ehrhart et al., 2003). 
 
Diagnosis 
The aortic body tumor has previously been diagnosed at necropsy but nowadays the tumors 
can be found with echocardiography (Nowakowski, H., VMD, PhD, pers. com., 2011). With 
radiography, a dorsal elevation of the trachea near the heart base can be observed. Other 
lesions seen with radiography include a peri hilar mass, pleural effusion and pulmonary 
edema (Ehrhart et al., 2003). However, diagnosis can be confirmed by immunohistochemistry 
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on biopsy. Gasometric blood tests can be performed on Boxers to see if they are at risk for 
aortic body tumors (Noszczyk-Nowak et al., 2010).  
The tumors express neuroendocrine markers that can be used for immunohistochemical 
labeling e.g. neuron specific enolase (NSE), synaptophysin and chromogranin A (CrA), and 
S-100 (Deim et al., 2007; Aresu et al., 2006). The immunohistochemical labeling should be 
combined with a standard hematoxylin and eosin staining to confirm the diagnosis 
(Noszczyk-Nowak et al., 2010). NSE is a monoclonal antibody that labels neoplastic and 
normal cells of neuroendocrine and neuronal origin. Synaptophysin is a monoclonal or 
polyclonal antibody used for detection of endogenous levels of total synaptophysin protein. It 
detects neuroendocrine neoplasms of neural origin by reacting with a hydrophilic sequence of 
synaptophysin. Chromogranin A is a polyclonal antibody that reacts with chromogranin A in 
neuroendocrine cells. Neuroendocrine tumors can contain chromogranin A and therefore the 
antibody can be used for detection of such tumors. S-100 is also a polyclonal antibody that 
labels ependynomas, astrogliomas, Schwannomas and also nearly all malignant and benign 
melanomas and their metastases (Abcam, 2011).  
Aresu et al. (2006) performed a study to see if the malignancy of the tumors could be decided 
with immunohistochemical markers. NSE, CrA and S-100 were used as markers and detectors 
of malignancy. 17 canine aortic body tumors were used and divided into three separate 
groups; I, II and III. There were no tumors classified as group I in the study. See table 1 for 
details.  
Table 1. Classification of aortic body tumors in the study (After Aresu et al., 2006) 
 
Tumor group I Tumor group II Tumor group III 
Benign Malignant Malignant 
Low mitotic rate 
< 2 per high field 
Low mitotic rate 
< 2 per high field 
High mitotic rate 
>  4 per high field 
Uniform cells Less uniform cells - 
No evidence of locally 
infiltrative growth or 
metastasis 
Evidence of locally infiltrative 
growth or metastasis 
Evidence of locally infiltrative 
growth or metastasis 
0 cases in the study 8 cases in the study 9 cases in the study 
 
All 17 tumors were positive for NSE which was expected since the type I cells are positive for 
NSE. The group III tumors were negative for CrA whereas the group II tumors were positive 
for CrA. All grade II tumors and one grade III were positive for S-100. The nuclei of the 
sustentacular cells were positive for S-100. Chromogranin is specific for neuroendocrine 
tumors and negative or weak staining indicated lack of chromogranin granules. A negative 
staining with S-100 indicated an absence or reduced number of sustentacular cells. In 
conclusion; negatively staining for S-100 and CrA indicated a malignant behavior and can 
therefore be used as a criteria for determination of malignancy of an aortic body tumor.  
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DISCUSSION 
The purpose of this essay was to describe the macroscopic and microscopic appearance of 
canine aortic body tumors along with the patophysiology, diagnosis and prognosis. Based on 
their size and location these tumors might be more common than previously believed. A 1 cm 
big tumor located in the adventitia of the aorta might be overlooked during necropsy and 
because of that the prevalence might be higher than reported.  
Many of the authors states that the tumors are mostly benign but can infiltrate the surrounding 
organs and vessels causing dyspnea, cough, pulmonary edema, pericardial effusion, 
hydrothorax, hydropericardium, fatigue, edema, weight loss, vomiting and Vena Cava 
syndrome. On the other hand Yates et al. (1980) reports that 22 % of all tumors will 
eventually metastasize despite their benignant behavior. The different opinions might be 
based on how they categorize malignant and benign. Perhaps Yates considers infiltration as a 
malignant behavior and categorizes it as metastasizing.  On the other hand the length of Yates 
study was 12 years and he followed all the cases and with time a benign tumor might 
metastasize and thereby convert into a malignant tumor. Many of the other studies are single 
case studies and maybe they did not have the opportunity to follow each case and see how the 
tumor might evolve. Another difference might be euthanasia; Yates cases lived between 1967 
and 1979 and many of the other case studies are from the 1990’s and 2000’s and there might 
be a different opinion now about euthanasia than during the 1960’s and 1970’s. Perhaps 
nowadays the owners are keener of euthanizing if they feel their dog suffers and thereby the 
development of the tumors can not be followed.  
More research has to be done on the etiology, at the moment the etiology is mainly based 
upon theories. Chronic hypoxia has been confirmed to cause hyperplasia of chemoreceptor 
organs and hyperplasia can result in neoplasia. Since BAS causes chronic hypoxia it seems 
like a possible causing factor except for the fact that not all of the brachycephalic dogs have a 
higher prevalence of aortic body tumors. Genetic predisposition among different breeds 
combined with BAS could be the reason why aortic body tumors are more common in certain 
breeds such as Boxer. Research should be done on whether a combination of genetic 
predisposition and BAS increases the incidence of aortic body tumors. If a connection can be 
made between the two theories there might be a way to control if certain individual are at risk. 
Noszczyk-Nowak et al. (2010) took gasometric blood tests on Boxers to see whether they 
were at risk or not. This technique might be performed on other breeds to be able to see if 
they are at risk.  
A weakness in the literature is the almost non-existing distinction between malignant aortic 
body tumors and benign. Some authors made the distinction and some did not and as a reader 
it was hard to know whether the tumors discussed were malignant or benign. In most case 
reports the description of the tumors appeared to be general. In this essay a distinction 
between malignant and benign has been done when the literature made the distinction.  
In conclusion; more research should be done considering etiology and the distinction between 
malignant and benign tumors. More clinical tests should be developed to be able to detect the 
tumors at an early state to enhance the prognosis. As a veterinarian it is important to be aware 
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of the existence of aortic body tumors. Although they are uncommon they do exist and should 
not be neglected when a dog with pericardial effusion, cough and dyspnea needs medical 
expertise.  
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